Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Since their discovery in Mycobacterium tuberculosis (Mtb), F-dependent enzymes have been identified as both important drug targets and potential industrial biocatalysts, including for bioremediation of otherwise recalcitrant substrates. Mtb-FGD1, utilizes glucose 6-phosphate (G6P) as an electron donor for the reduction of F. Current expression systems for Mtb-FGD1 use Mycobacterium smegmatis as host, because of the tendency for it to form inclusion bodies in E. coli. However, large scale recombinant protein production using M. smegmatis is slow and costly and the organism is not generally recognized as safe. Here, we report a faster, cheaper and safer approach for the expression of fully functional Mtb-FGD1 in E. coli using cold-adapted GroEL/ES as chaperones. Our approach yielded ∼70 mg of protein per litre (L) of culture. The purified enzyme catalysed the reduction of F to F.H in the presence of G6P, and the re-oxidation of the F.H to F when coupled to Tfu-FNO, which is a thermostable oxidoreductase that utilizes F for the reversible oxidation of NADPH. This latter finding provides opportunity for the utilization of Mtb-FGD1 as an industrial biocatalyst or in the detoxification of environmental contaminants such as malachite green, picrate and aflatoxin.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pep.2024.106650DOI Listing

Publication Analysis

Top Keywords

mycobacterium tuberculosis
8
expression purification
4
purification mycobacterium
4
tuberculosis f-dependent
4
f-dependent glucose-6-phosphate
4
glucose-6-phosphate dehydrogenase
4
dehydrogenase enzyme
4
enzyme escherichia
4
escherichia coli
4
coli discovery
4

Similar Publications

Maintaining safe and potent drug levels in vivo is challenging. Multidomain peptides assemble into supramolecular hydrogels with a well-defined, highly porous nanostructure that makes them attractive for drug delivery. However, their ability to extend release is typically limited by rapid drug diffusion.

View Article and Find Full Text PDF

This research work details the use of a molecular hybridization technique to create a library of four series of hydrazineyl-linked imidazo[1,2-]pyrimidine-thiazole derivatives. The structure of one of the final products, K2, was validated using single-crystal X-ray diffraction. Twenty-six novel hybrid molecules (K1-K26) were synthesized and tested for activity against the H37Rv strain.

View Article and Find Full Text PDF

Case Report: Sarcoidosis or tuberculosis? A continuous challenge.

Front Med (Lausanne)

August 2025

Department of Pulmonology, Institute of Pneumology, Bucharest, Romania.

Sarcoidosis is a multisystem granulomatous disorder of unknown etiology, characterized by the formation of non-caseating granulomas in affected tissues and organs. In over half of the cases, the disease undergoes spontaneous remission. In contrast, tuberculosis (TB) is an infectious disease caused by , which, if left untreated, can be fatal.

View Article and Find Full Text PDF

Tuberculosis (TB) is a multisystem infectious disease with both pulmonary and extrapulmonary manifestations. TB can also induce a hypercoagulable state, setting off a cascade of changes in the body, including systemic inflammation, endothelial dysfunction, and abnormalities in the coagulation and fibrinolytic pathways. Collectively, these factors significantly increase the risk of venous thromboembolism, such as deep vein thrombosis and pulmonary embolism.

View Article and Find Full Text PDF

A 27-year-old man from Ethiopia had undergone an extraction of a molar in Libya ten months earlier, after which a submental swelling developed. For that reason, an oral and maxillofacial surgery department was consulted. Clinical examination showed a tender, firm-to-the-touch, non-mobile swelling with central ulceration.

View Article and Find Full Text PDF